Tuesday, June 16, 2009
Father's Day Gift Ideas for Dads with Diabetes
Thursday, June 04, 2009
New Treatments Offer Hope for Type 2 Diabetes
In this article, new medications and types of insulin continue to come forward each year. There are types of insulin ranging from rapid-acting to short-acting to long-acting. Multiple categories of diabetes pills are helpful ranging from sulfonylureas, biguanides, thiazolidinediones, alpha-glucosidase inhibitors, and meglitinides. All work in different ways to lower blood sugar, stimulate the pancreas to release more insulin, improve insulin's effectiveness, or block enzymes that help digest starches to slow the rise in blood sugar.
In the past two to four years, two treatments have emerged as growing choices among diabetic patients because they show the ability to effectively control diabetes with little risk of weight gain, a side effect for many patients.
Friday, May 15, 2009
Diagnosing and Monitoring Diabetes using a Spit Test
If the research pans out — would forego needle-pricking patients, especially unappealing to the growing number of children with the condition. Instead, patients could simply spit into a cup. It also would cost a lot less as well.
Through the course of his team's research, Nagalla estimates they identified 487 unique proteins, approximately a third of which had not been previously found in human saliva. Of those, 65 proteins indicated a difference between patients with normal blood glucose levels and those with diabetes.
That doesn't rule out using traditional methods of testing diabetes, as using traditional monitors result in more accurate readings.
[Read the entire article here]
Thursday, April 30, 2009
The Cure for Diabetes? A Healthy Diet
Thursday, April 23, 2009
Enjoy Great Tasting Recipes for Diabetics
Here is a great recipe that is diabetic friendly for Oatmeal Cookies!
In order to make these diabetic cookies, you'll need the following ingredients:
* 1/2 c. margarine
* 1 egg
* 1 tsp. sucaryl solution
* 1/4 c. milk
* 1 c. flour
* 1/2 tsp. baking powder
* 1/8 tsp. baking soda
* 1 tsp. cinnamon
* 1/2 tsp. nutmeg
* 1/4 tsp. salt
* 1 tsp. vanilla
* 1/2 c. raisins
* 1 c. rolled oats
Cream margarine until smooth. Add beaten egg, sucaryl solution, and milk. Sift and mix dry ingredients and then add to first mixture. Beat in vanilla, raisins, and rolled oats. Drop by teaspoon onto greased cookie sheet and bake. You can use 1/4 cup margarine and 1/4 cup applesauce or 1 banana instead of using the full amount of margarine.
Check out the American Diabetes website for more dessert recipes, as well as side dishes, entrees and appetizers!
Monday, September 10, 2007
Freedom Medical Services expands into online pharmacy
Patients of both companies will benefit from the product selection and customer care. Freedom Med will help with all their medical needs.
Wednesday, August 29, 2007
Elixir moves diabetes drug into Phase 3 trials
According to an article on diabetes medicine clinical trials, Elixir Pharmaceuticals Inc. has initiated a Phase 3 clinical trial of its drug for type 2 diabetes, officials report.
The Cambridge-based biotech reports its drug, mitiglinide, is designed to help diabetics control their blood sugar and assist them in producing insulin. Company officials said they hope to seek approval of the drug from the U.S. Food and Drug Administration somtime during 2009.
The Phase 3 study involves 300 patients at 50 sites in the United States, according to the company. The trial is expected to conclude in the middle of 2008.
If you have type 2 diabetes and you're on Medicare, you may qualify for a free glucose meter. Visit American Diabetes Services to find out.
Tuesday, August 14, 2007
Can Selenium Really Prevent Type 2 Diabetes?

Results of a randomized clinical trial using 200 micrograms of selenium alone showed that 55 percent more cases of type 2 diabetes developed among participants randomized to receive selenium than in those who received a placebo pill.
"Among participants taking selenium supplementation, those who had the highest levels of selenium in their circulation at the beginning of the study had the highest risk of developing type 2 diabetes over the average 7.7 years of follow-up," he said, "and the increase in risk is unlikely to be a result of chance."However, in the general population, very few people, if any, take selenium supplements only, every day, for nearly eight years, so we can't be sure that these findings apply to the public at large.
For more information about diabetes and to see if you or someone you know may qualify for free diabetic supplies, vist www.AmericanDiabetes.com.
Tuesday, July 31, 2007
Dentists May Be Able To Determine If You Have Diabetes
Dr. Ruth Cauthen of Ghent Family Dentistry helped 61-year-old Ronald Branch with his health and his job. He was struggling with controlling his blood sugar for two years, and his primary care physician was about to put him on insulin. Doctor Cauthen knew she could help.
Dr. Cauthen pulled 14 of Ronald's teeth and got the periodontal disease under control. An infection can wreak havoc on diabetics. Once the infection was gone, Ronald's blood sugar improved.
Dr. Sheila Garris is hoping for more success stories like this. She recently attended a conference in Scottsdale, Arizona with diabetes experts and dentists. They're leading the way for dentists and doctors to work closer together helping diagnose periodontal disease and diabetes. Dr. Garris said, "Dentists may be the first people to identify diabetes by identifying periodontal disease and primary care may be the first ones to recognize periodontal disease, and they're going to need the help of the dentists to help control the diabetes."
Tuesday, July 17, 2007
Study May Set New Bar for Gestational Diabetes
They said the seven-year international study, presented at the American Diabetes Association meeting in Chicago, may spark a new look at where to draw the line for diagnosing a woman with gestational diabetes. The condition -- in which a woman who has never had diabetes loses her ability to use insulin properly during pregnancy -- affects about 4 percent of all pregnant women. In the United States, there are about 135,000 cases of gestational diabetes each year.
Treatment usually consists of diet and exercise. If left untreated, the mother can transfer extra blood sugar to the fetus, causing the fetus' pancreas to make extra insulin to handle the overload of sugar. This extra energy can produce large babies that may have trouble breathing at birth and could become obese as a child and develop diabetes in adulthood.
The study, led by Dr. Boyd Metzger of Northwestern University's Feinberg School of Medicine in Chicago, involved 23,325 women at 15 centers in nine countries who were tracked during pregnancy. What Metzger and colleagues found is that the higher a woman's blood glucose got, the more likely the child was to be large, to be delivered by Caesarean section, to have low blood glucose needing treatment and to have high levels of insulin. "We found that some problems occurred even in ranges previously considered within the normal range for pregnant women," Metzger said in a statement.
He said it is likely that the level of a mother's blood glucose used to diagnose gestational diabetes will be lowered based on the study's findings. The study was funded by the National Institutes of Health and the American Diabetes Association.
Tuesday, July 03, 2007
World Waking up to Diabetes Crisis
There are the obvious opportunities for the insulin producers, but as diabetes can lead to blindness, heart disease, strokes and amputations, a wider group of drug makers could be involved.
Diabetes will this year kill as many people around the world as Aids, prompting scientists to call the fast-growing disease the greatest epidemic of current times.
Signs that developing countries are preparing to put some of their stretched budgets into fighting diabetes is not just good news for their people. It could create an opportunity for the drug industry. Not only will there be a large growth of diabetes sufferers in rich countries, where patients can afford the latest treatments, but the explosion of diabetes in poor countries creates an opportunity for Big Pharma to enter new markets where prices are low but volumes large.
Lars Rebien Sorensen, chief executive of Novo Nordisk, the world's largest maker of insulin, said: "Diabetes is growing fastest in Africa, Asia and Latin America. "At the same time we are seeing pressure on the US healthcare system, where there could be price controls. That is going to put pressure on global growth."
There are also opportunities to develop low-cost blood sugar monitors and even solar-powered fridges to store insulin.
The world is on the cusp of recognising the crisis and funds such as the foundation set up by former US President Bill Clinton are beginning to show an interest in creating a global fund to pay for diabetes medicines, in the same way that a fund was established for malaria, tuberculosis and Aids medicines.
One of the world's most eminent scientists working on diabetes, Paul Zimmet of Australia, told the gathering in Nairobi: "There are competing conflicts - HIV, malaria, earthquakes, Sars, climate change and water shortages. But diabetes is one of the greatest epidemics in world history."
If you have been recently diagnosed with diabetes, you may be able to get your meter and testing supplies for free. Medicare and most private insurance companies pay for these products. For more information, please visit http://www.freedomed.com.
Tuesday, June 19, 2007
Medical Advances Against Diabetes Haven't Benefited Women, Study Says
According to a recent article, researchers found that the death rates of diabetic men dropped in recent decades, while those of diabetic women increased. It's not clear why the discrepancy exists. "I do not have a clue," said Dr. Larry Deeb, President of Medicine and Science for the American Diabetes Association (ADA), when asked why women are falling behind. "But I do know that it argues that something we're doing isn't right. If you're a woman, and you have diabetes, it may be we're not aggressive enough about taking care of you."
In the new study, researchers led by Edward Gregg, an epidemiologist with the U.S. Centers for Disease Control and Prevention, examined health surveys spanning 1971 to 2000 to determine the death rates of Americans with diabetes. The researchers looked at about 27,000 people.They found that among diabetic men, the death rate from all causes dipped from 42.6 to 24.4 deaths per 1,000 persons between the two time periods. But among diabetic women, the death rate actually rose from 18.4 to 25.9 per 1,000, even as the life span of non-diabetic women grew longer.
An estimated 9.7 million American women have diabetes, and almost one-third of them don't know it. Women with diabetes are more likely to have a heart attack, and at a younger age, than women without diabetes, according to the ADA.
For more information about diabetes and related services, please visit the diabetic resource center at http://www.freedomed.com.
Monday, June 11, 2007
Rheumatoid Arthritis Drug May Help Treat Type 2 Diabetes
Sometimes, beta cells -- insulin-producing cells -- in the pancreas are destroyed in type 2 diabetes as they are in type 1 diabetes. Through previous research, the study’s authors learned that a substance called interleukin-1 beta was a factor in the demise of these cells in people with type 2 diabetes. The drug Anakinra is an interleukin-1-receptor antagonist, which means it can block the action of interleukin-1 beta. "Our study is proof of concept for a mechanism underlying the disease and (may possibly) block its progression," said Dr. Marc Donath, one of the study’s authors, who added, "Interleukin-1 beta may be involved in other complications of the disease, such as arteriosclerosis. Therefore, this therapy may also prevent cardiovascular events. However, this remains to be shown."
Anakinra was well tolerated by the study participants, and Donath and his colleagues plan on conducting larger, follow-up studies of the medication. "This study points to inflammation as definitely having a role in the (diabetes) story," said Dr. Stuart Weiss, an endocrinologist at New York University Medical Center, and a clinical assistant professor of medicine at the New York University School of Medicine. But, Weiss said that while this avenue of research is "worth pursuing, I wouldn't get my hopes up for a clinical application, especially since the drug appears to lose its effectiveness over time." Additionally, Weiss pointed out that it appeared the drug was more effective in thinner people. "The authors don't really discuss this, but it's an interesting finding -- it's not what we'd expect."
For more information about diabetes and services for diabetics, please visit American Diabetes Services.
Monday, February 19, 2007
Diabetes Expert Preaches La Vida Low-Carb
In December 2006 she became more widely known as she was featured in Men’s Health magazine. It was then that her efforts were brought to the forefront and she is now receiving the recognition earned for being at the forefront of the cutting edge advances being made in diabetes treatment.
According to Dr. Vernon, incorporating a low-carb diet in everyday life is the best way to keep diabetes in check. As she says, “Carbohydrate control is the best way to manage both types of diabetes -- the type with high levels of insulin secretion (usually called Type 2) and the type with no insulin secretion (usually called Type 1). In the case of high insulin secretion, low levels of dietary carbs bring the insulin levels down, which stops your body from storing fat and allows your body to begin to burn fat. This allows your body to begin to return to normal levels of blood sugar.” She has seen tremendous improvement in her patients once they make the change to the low-carb lifestyle.
Dr. Vernon further contends, “Giving [patients] control over their diabetes by giving them the tools to eat in such a way that they require less medication”.
For more information about diabetes and services for diabetics, please visit American Diabetes Services.
Monday, February 12, 2007
Tokyo Team Uncovers Possible Diabetes Cure
Visceral fat (also known as internal fat) was long suspected a culprit for the onset of Type-II diabetes. When it accumulates (most often in overweight older adults), adiponectin decreases. Adiponectin is a protein hormone responsible for several metabolic processes including glucose regulation and the breakdown of fatty acid. Adiponectin works to lower blood sugar and neutral fat levels. A decline in this hormone can cause metabolic syndrome; resulting in diseases such as diabetes.
This study has revealed the inner workings of this process that were previously unclear. In tests involving mice, the researchers found two types of protein on the surface of the liver cells. Blood sugar and neutral fat levels fall when proteins and adiponectin join – which boosts fat-burning functions. Obese mice however, have visceral fat accumulated and fewer proteins on the surface of their liver cells. So when the researchers found increased proteins, the blood sugar levels would decline. The research team found that even if the quantity of adiponectin decreased in obese people, diabetes could be cured if the proteins increased.
If you or someone you know has Type-II diabetes , you may qualify for free diabetes supplies. Visit American Diabetes Services to find out.
Sunday, February 04, 2007
Oral Insulin Tested to Prevent Type I Diabetes
The study tests a group of individuals most likely to develop the condition by administering an oral dose of insulin to see if it will prevent or delay its onset.
A pilot study called “The Nutritional Intervention to Prevent Type 1 Diabetes (NIP) Trial” is also being conducted on docosahexaenoic acid (DHA), an omega-3 fatty acid, to see whether it could be used to prevent the disease in infants less than five months old.
Diabetes is a disorder characterized by high blood sugar. Type I diabetes creates an autoimmune response that destroys the insulin producing cells while type 2 is a general insulin resistance. For more information about diabetes, related services and links, visit American Diabetes Services.
Sunday, January 28, 2007
10-Year Old Boy Uses the Promise Ball Silent Auction to Give Back to the Medical Community – Phoenix, Arizona
Miniature horses stand about 38 inches high and Andrew’s “mini,” named Zig Zag, was expected to start the bidding at $3,000. The only prerequisites for bidding were that the winners love him, enter him in contests and let him play in a proper field. Zig Zag is also a mini-celebrity in some circles. As a yearling, the light brown and white 4-year-old registered miniature show horse had been entered at various festivals and contests.
The Desert Southwest Chapter of the Juvenile Diabetes Research Foundation International holds the Promise Ball every winter. JDRF Desert Southwest Chapter's seventh Annual Promise Ball raises money for research to find a cure for type 1 diabetes and its complications. In 2006 , the Ball raised an astounding $2.2 million and netted $1.9 million to support research. For more information on the Juvenile Diabetes Research Foundation International, visit jdrf.org
Thursday, November 30, 2006
National Diabetes Awareness Month - Last Chance to Donate
Every November, the American Diabetes Association encourages the public to learn more about Type 2 diabetes and the risks associated with the disease through National Diabetes Awareness Month. American Diabetes Services, which provides low cost or free diabetic self testing supplies to those with Medicare or qualifying insurance, supported these efforts by continuing to provide online education about this disease.
Don't Forget - Today is the last day your donations can be doubled to the American Diabetes Association. Call today at 1-800-DIABETES (800-342-2383). Your monies will go towards important diabetic research to help find a cure for Type 2 diabetes.
Wednesday, October 25, 2006
More Warnings on Counterfeit Diabetic Test Strips
Last week, FDA issued a nationwide alert on counterfeit One Touch Basic/Profile and One Touch Ultra diabetic test strips. The Oct 23rd announcement provides two additional lot numbers of conterfeit diabetic test strips, along with descriptions of how to identify them.
The new counterfeit diabetic test strips are:
- One Touch Basic®/Profile® lot #2615211
- One Touch Ultra® lot #2691261
Counterfeit One Touch Basic/Profile Test Strips, lot number 2615211
- The lot number 2615211 appears on the outer carton and on the inner container (vial).
- The outer carton is written in English.
- The outer carton is labeled as 50-Count One Touch (Basic/Profile) Test Strip packages.
- A picture of a hand appears on the test strip displayed on the outer carton.
- The inner container is labeled as “plasma-calibrated”.
Counterfeit One Touch Ultra Test Strips, lot number 2691261
- The lot number 2691261 appears on the outer carton and on the inner container (vial).
- The outer carton and the inside container (vial) are written in both English and French.
- The outer carton is labeled as 50-Count One Touch Ultra Test Strip packages.
- The bottom of the outer carton does not include an NDC number.
Monday, October 16, 2006
Counterfeit Diabetic Test Strips
LifeScan, makers of OneTouch Basic and OneTouch Ultra alerted FDA of the counterfeit diabetic test strips, which resulted in FDA in issuing a nationwide alert. The counterfeit diabetic test strips were distributed to pharmacies and stores nationwide--but primarily in Ohio, New York, Florida, Maryland and Missouri--by Medical Plastic Devices, Inc., Quebec, Canada and Champion Sales, Inc., Brooklyn, N.Y.
The counterfeit diabetic test strips can be identified by the following characteristics:
Counterfeit One Touch Basic/Profile Test Strips
- Lot Numbers 272894A, 2619932 or 2606340
- Multiple Languages- English, Greek and Portuguese text on the outer carton
- Limited to 50-Count One Touch (Basic/Profile) Test Strip packages
Counterfeit One Touch Ultra Test Strips
- Lot Number 2691191
- Multiple Languages- English and French text on the outer carton
- Limited to 50-Count One Touch Ultra Test Strip packages